Filter
392
Filtered Results: 392
Text search:
Shigella
Featured
Recommendations
49
New Publications
98
Language
Document type
No document type
199
Guidelines
79
Studies & Reports
45
Manuals
21
Strategic & Response Plan
14
Fact sheets
13
Training Material
10
Situation Updates
9
Infographics
2
Countries / Regions
India
17
Africa
11
Congo, Democratic Republic of
11
Rwanda
9
South Africa
9
Senegal
8
Ethiopia
8
Liberia
8
Kenya
7
Latin America and the Carribbean
7
Tanzania
7
Germany
7
Nepal
6
Nigeria
6
Burkina Faso
6
Global
6
Western and Central Europe
6
Bangladesh
6
Philippines
5
Ukraine
4
Sierra Leone
4
Zimbabwe
4
Guinea
4
Mozambique
4
Paraguay
4
Uganda
4
Ghana
3
Malawi
3
Mali
3
Myanmar / Burma
3
Syria
2
Peru
2
Haiti
2
West and Central Africa
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Russia
2
Yemen
2
Indonesia
2
North Macedonia
1
Colombia
1
Thailand
1
Lesotho
1
Togo
1
Cameroon
1
Iran
1
Niger
1
Afghanistan
1
Morocco
1
Cambodia
1
Guinea-Bissau
1
Jordan
1
South–East Asia Region
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Uruguay
1
Mauritius
1
United Kingdom
1
Bolivia
1
Vietnam
1
Papua New Guinea
1
Brazil
1
Angola
1
Chad
1
Zambia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
127
Clinical Guidelines
53
Key Resources
42
Women & Child Health
32
Capacity Building
15
Public Health
11
Pharmacy & Technologies
9
Toolboxes
AMR
75
Rapid Response
40
Cholera
30
Ebola & Marburg
29
Pharmacy
23
Planetary Health
12
HIV
10
Natural Hazards
9
Caregiver
9
Refugee
8
Conflict
7
TB
6
COVID-19
6
NTDs
4
Global Health Education
3
Mental Health
2
Specific Hazards
1
Health Financing Toolbox
1
NCDs
1
Zika
1
Polio
1
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali...
Características farmacológicas y clínicas más relevantes de los Medicamentos Esenciales utilizados en el manejo de las enfermedades infecciosas prevalentes en el primer nivel de atención. La misma se agrupa a su vez en: antibióticos, antimicóticos, antivirales, antiparasitarios y fármacos pa...
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...
Antimicrobial resistance has become a serious public health threat for effective treatment of an ever increasing range of infections caused by bacteria, parasites, viruses and fungi. When infections can no longer be treated by first-line antibiotics, other antibiotics must be used, which are both mo...
La vigilancia de la resistencia a los antimicrobianos (RAM) desempeña un papel importante en la detección temprana de cepas resistentes que revisten gran importancia para la salud pública, así como en la respuesta rápida a los brotes en los hospitales y en la comunidad. Los resultados de la vig...
Abordaje desde la salud pública
This open access book not only describes the challenges of climate disruption, but also presents solutions. The challenges described include air pollution, climate change, extreme weather, and related health impacts that range from heat stress, vector-borne diseases, food and water insecurity and ch...
Manual para la primera fase de implementación
Third edition.
The main changes within the third edition of the JEE tool include the split of the technical area National legislation, policy, and financing into two technical areas (Legal instruments and Financing); the drop of the technical area previously titled Reporting and the move of indicat...
Accessed Febr. 6, 2020
Les maladies infectieuses sont en constante mutation. De nouvelles maladies apparaissent, d’autres qui sont bien connues se propagent ou refont surface, et quelques rares fois, une maladie est éradiquée. Les maladies infectieuses telles que le VIH, la tuberculose et le choléra sont des causes c...
